Navigation Links
The New York Times Bestselling Thriller, WIRED, Now Being Given Away on Amazon (Unlimited Copies)
Date:8/23/2013

New York, New York (PRWEB) August 23, 2013

The riveting biotech thriller, WIRED, by Douglas E. Richards, a New York Times and USA Today bestseller, was Amazon's #1 novel in two major categories—science fiction and technothrillers—an unprecedented achievement. Now, to celebrate the launch of Richards's new thriller, THE CURE, the eBook version of WIRED will be free on Amazon on August 23rd, 24th, and 25th. LINK TO FREE COPY

THE CURE will be launched as a hardcover and eBook on September 17th by Tor/Forge and can be preordered now. In THE CURE, Erin Palmer suffers through a devastating encounter with a psychopath as a young girl. Now a grad student and scientist , she’s devoting her life to studying these monsters. When her research catches the attention of Hugh Raborn, a brilliant neuroscientist who claims to have isolated the genes responsible for psychopathic behavior, Erin realizes it may be possible to reverse this condition, restoring souls to psychopaths. But to do so, she’ll not only have to operate outside of the law but violate her most cherished ethical principles.

Psychopaths seem to be at epidemic levels. THE CURE provides an eye-opening look at what is known about psychopathy within an intriguing, explosive, roller-coaster-ride of a novel that will keep both thriller fans and science fiction fans reading deep into the night.

“Richards is a tremendous new talent. The Cure is an extraordinarily good novel that will keep you riveted . . . and thinking.”
—Stephen Coonts, 17-time New York Times bestselling author of Pirate Alley

“The Cure will keep you turning the pages all night long.”
—Douglas Preston, #1 New York Times bestselling author of Impact

The Cure will be released on Sept 17th and will be available everywhere books are sold.

LINK TO FREE COPY OF WIRED

Read the full story at http://www.prweb.com/releases/2013/8/prweb11037973.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Sanovas CEO Larry Gerrans Featured at BayBios Fundraising in Troubled Times
2. Probiotic Action Announces Further Exploration of Probiotics for Acne with New Information from the LA Times
3. New Research Suggests Probiotics May Lower Cholesterol, Probiotic Action Reports with Insight from the New York Times
4. Riveting NY Times Bestselling Biotech Thriller, WIRED, Now Only $5.95 for Kindle Owners
5. The #1 Science Fiction Novel of 2011 (and NY Times Bestseller) Now Only $5.95
6. National Defense Industrial Association's (NDIA) 2012 Biosurveillance Conference To Feature Keynote Speaker Laurie Garrett, Pulitzer Prize Winner and Bestselling Author
7. Riveting Biotechnology Novel, WIRED, Becomes the #1 Technothriller on Amazon
8. Riveting Biotechnology Novel, WIRED, Becomes the #1 Technothriller on Amazon
9. Riveting Biotechnology Novel, WIRED, Becomes the #1 Technothriller on Amazon
10. Riveting Biotechnology Novel, WIRED, Becomes the #1 Technothriller on Amazon
11. Breast Cancer Vaccine Being Developed by Generex Subsidiary Antigen Express to be Featured on Bloomberg Television Today
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... 2017 ... share data, unaudited)Three Months Ended December 31,Twelve Months Ended ... $           ... 89026%Aldurazyme Net Product Revenue 3539(10)%9498(4)%Kuvan ... Product Revenue  756025%297303(2)%Vimizim Net Product ...
(Date:2/23/2017)... 23, 2017  MIODx announced today that it ... immunotherapy technologies from the University of California, San ... to monitor a patient for response to immune ... The second license extends the technology with a ... to have an immune-related adverse event (IRAE) from ...
(Date:2/23/2017)... ROCHESTER, Minn. , Feb. 23, 2017 /PRNewswire/ ... a new product line of oncolytic vaccinia viruses ... Genelux Corporation as part of Genelux,s proprietary, vaccinia ... "We are excited to enter into a partnership ... time, selected oncolytic vaccinia viruses for use in ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... annual Inventors Recognition Reception at Purdue Research Park of West Lafayette, ... in recognition of outstanding contributions to, and success with, commercializing discoveries from Purdue ...
Breaking Biology Technology:
(Date:2/10/2017)... Research and Markets has announced the addition ... and Commercial Aspects" to their offering. ... Biomarkers play an ... for selection of treatment as well for monitoring the results. ... in modern medicine. Biochip/microarray technologies and next generation sequencing are ...
(Date:2/8/2017)... Report Highlights ... The global synthetic-biology market reached nearly $3.9 ... growing at a compound annual growth rate (CAGR) of 24.0% ... global markets for synthetic biology. - Analyses of global market ... of compound annual growth rates (CAGRs) through 2021. - Coverage ...
(Date:2/7/2017)... , Feb. 7, 2017 Zimmer Biomet ... in musculoskeletal healthcare, will present at the LEERINK Partners ... York Palace Hotel on Wednesday, February 15, 2017 at ... webcast of the presentation can be accessed at ... following the conference via Zimmer Biomet,s Investor Relations website ...
Breaking Biology News(10 mins):